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Summary 
Infection with feline immunodeficiency virus (FIV)  leads to the development of a 
disease state similar to AIDS in man. Recent studies have identified the chemokine 
receptor CXCR4 as the major receptor for cell culture-adapted strains of FIV, 
suggesting that FIV and human immunodeficiency virus (HIV) share a common 
mechanism of infection involving an interaction between the virus and a member of 
the seven transmembrane domain superfamily of molecules. In this article, we review 
the evidence for the involvement of chemokine receptors in FIV infection and 
contrast these findings with similar studies on the primate lentiviruses HIV and SIV 
(simian immunodeficiency virus). 
 
Introduction 
  Feline immunodeficiency virus (FIV) is a widespread pathogen of the 
domestic cat, infection resulting in an immune dysfunction characterised by a 
progressive depletion of CD4+ lymphocytes from the peripheral blood (Ackley et al. 
1990; Novotney et al. 1990).  Lentiviruses  have also been identified in non-domestic 
felids such as the Pallas cat (Barr et al. 1997), pumas (Langley et al. 1994) and lions 
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(Brown et al. 1994).  Phylogenetic analyses have demonstrated that  the lion and 
puma lentiviruses  (LLV and PLV respectively) are more closely related to FIV than 
to either  the primate or the ungulate lentiviruses. However, whether PLV or LLV 
induce an immunodeficiency in their natural host is unclear; in many cases infection 
may be inapparent as has been observed with SIVSM infection in the sootey 
mangabey.  Indeed, amino acid sequence comparisons between the envelope 
glycoproteins of FIV and PLV-14 revealed only 8% similarity (37% nucleic acid 
similarity) (Langley et al. 1994) suggesting an ancient divergence between FIV and 
PLV. 
 FIV infects a range of CD4-negative cell types including 
monocyte/macrophages (Brunner and Pedersen, 1989), B cells (Dean et al. 1996; 
English et al. 1993) and cells of neuronal lineage (Dow et al. 1990), and CD4 
expression in vitro does not correlate with susceptibility to infection with FIV (Willett 
et al. 1991).   Indeed, CD4 expression in the cat is restricted to T-helper lymphocytes 
and their thymic precursors and unlike in human beings it is not expressed on 
monocytes and macrophages.  While the principal in vivo target of FIV  during early 
infection appears to be the CD4+ T cell, with increased time post-infection the major 
reservoir for proviral DNA appears to be CD21+ lymphocytes (B-cells) and CD8+ T-
cells (Dean et al. 1996; English et al. 1993).  Whether B-cells are productively 
infected with FIV, or whether viral uptake occurs via a complement-dependent 
mechanism as described for HIV (Boyer et al. 1991; Robinson et al. 1990) has yet to 
be ascertained, however, these studies provide compelling evidence for the existence 
of a non-CD4 receptor for FIV.  Indeed, ectopic expression of feline CD4 on 
feline cell lines of non-lymphoid origin does not render the cells permissive for 
infection with lymphotropic isolates of FIV (Norimine et al. 1993). 
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 FIV can be isolated readily from cultures of mitogen-stimulated peripheral 
blood mononuclear cells (PBMC) from the infected domestic cat, virus production 
being accompanied by a cytopathic effect characterised by syncytium formation, 
ballooning-degeneration and cell lysis.  The majority of these primary isolates of FIV 
can  be propagated only in cultures of fresh mitogen-stimulated PBMCs, thymocytes 
or interleukin-2 (IL-2)-dependent T cell lines.  However, some isolates of FIV adapt 
readily to growth in established feline cell lines such as the Crandell feline kidney cell 
line (CrFK).  Indeed, two molecular clones of the Petaluma isolate of FIV, namely  
F14 (Olmsted et al. 1989) and 34TF10 (Talbott et al. 1989) were derived from 
infected CrFK cells. These “CrFK-adapted” strains of FIV have an expanded cell 
tropism which permits infection of a wide range of feline cell lines. Furthermore, 
several non-feline cell lines, such as the canine cell line MDCK and the human cell 
line HeLa (Egberink et al. 1991), are susceptible to infection with CrFK-adapted 
strains of FIV.  Originally, it was thought that the mechanism underlying this 
expanded cell tropism of FIV was pseudotypic mixing between FIV and the feline 
endogenous retrovirus RD114 (Egberink et al. 1991), a retrovirus produced in large 
quantities by many feline cell lines including CrFK.  While pseudotypic mixing 
between FIV and RD114  has not been excluded, subsequent studies have 
demonstrated that transfection of human cells with plasmid vectors expressing the 
FIV envelope glycoprotein gene (env) from a CrFK-adapted strain of FIV resulted in 
syncytium formation (Pancino et al. 1995), suggesting that the viral envelope 
glycoprotein (Env) determines the expanded cell tropism of these types of virus.  In 
agreement with these findings, the critical determinant of CrFK-tropism was localised 
to the third variable region (V3 loop) of the Env protein.  Two independent studies 
demonstrated that an increase in the net charge of the V3 loop was sufficient to render 
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some primary isolates of FIV “CrFK-tropic” (Siebelink et al. 1995; Verschoor et al. 
1995).  The increase in charge resulted from the mutation of either of two glutamate 
residues (407 and 409) in the V3 loop to lysine residues (Figure1).  These studies 
mirrored observations made with HIV regarding the switch from an NSI (non-
syncytium inducing) to an SI (syncytium inducing) phenotype (de Jong et al. 1992) 
and suggested that CrFK-adapted strains of FIV and SI strains of HIV shared a 
common mechanism of infection. 
 
Identification of CXCR4 as a receptor for FIV 
 The identification of the orphan seven transmembrane domain receptor 
LESTR (lymphocyte expressed seven transmembrane domain receptor, subsequently 
re-named CXCR4 - the receptor for the α-chemokine SDF-1) as the principal cofactor 
for CD4-dependent infection with SI strains of HIV-1 (Feng et al. 1996) provided a 
molecular basis for the adaptation of HIV to grow in T cell lines; primary isolates of 
HIV were not able to use CXCR4 as a cofactor whereas those selected for growth in 
established cell lines interacted with CXCR4.   CXCR4 was therefore implicated in 
infection with CrFK-adapted strains of FIV.  As the envelope glycoprotein of CrFK-
adapted strains of FIV is able to induce cell-cell fusion in human cell lines (Pancino et 
al. 1995), the role of CXCR4 in FIV infection could be addressed directly by 
examining the ability of the anti-CXCR4 antibody 12G5 to inhibit fusion between 
FIV-infected CrFK cells and the human cell line HeLa.  Incubation of the cells in the 
presence of the antibody 12G5 resulted in a dose-dependent inhibition of syncytium 
formation (Willett et al. 1997). In contrast, cell fusion was not inhibited by incubation 
with either antibody recognising feline CD9 or a polyclonal goat serum raised against 
the envelope glycoprotein of the feline endogenous retrovirus RD114.  However, cell 
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fusion was inhibited efficiently by a monoclonal antibody recognising the FIV 
envelope glycoprotein as well as serum from an FIV-infected cat (Figure 2).  These 
data suggested that CXCR4 functioned as a cofactor for fusion mediated by CrFK-
adapted strains of FIV.  In order to address the role of CXCR4 in FIV infection 
directly, cDNAs encoding the feline homologue of CXCR4 were amplified by the 
polymerase chain reaction (PCR) utilising primers designed from regions of 
nucleotide sequence homology between the human, bovine and ovine CXCR4 
sequences. Using mRNA derived from either the feline T cell line Mya-1 or the CrFK 
cell line, cDNA clones were amplified by  PCR, cloned and the nucleic acid sequence 
determined (Willett et al. 1997). The predicted amino acid sequence of feline CXCR4 
displayed 94.9% amino acid identity to human CXCR4 compared with 90.5% identity 
to murine CXCR4.  The high degree of homology between human and feline CXCR4 
provided support for the proposal that fusion between the human cell line HeLa  and 
FIV-infected CrFK cells was mediated by CXCR4.  Subsequent studies demonstrated 
that transfection of the human cell line U87 with either human or feline CXCR4 
rendered these cells permissive for fusion with FIV-infected CrFK cells (Willett et al. 
1997).   
 In order to demonstrate that FIV interacts directly with CXCR4, binding 
studies were performed using 125I-labelled SDF-1α and a derivative of the human cell 
line U87 transfected stably with feCXCR4 (Hosie et al. 1998).  SDF-1 was found to 
interact  with feline CXCR4 with a high affinity (SDF-1α with a KD of 12.0 + 5.3 nM, 
SDF-1β with a KD of 10.4 + 1.5nM).  Immunoaffinty purified Env protein from the 
CrFK-adapted isolate of FIV (FIVPET) competed with SDF-1 for binding to feline 
CXCR4, KD = 0.48 + 0.16nM.  Previous studies using HIV-1 IIIB gp120 
(Hesselgesser et al. 1997) had demonstrated displacement of SDF-1 binding, KD=70 + 
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26nM, indicating that the binding affinity of FIV Env and CXCR4 was very high.  
However,  the HIV-1 IIIb gp120 binding studies were performed with CD4-negative 
human neurones and infection with HIV-1 IIIB is CD4-dependent; this may account 
for the lower affinity interaction between the IIIB gp120 and CXCR4. As yet, binding 
of envelope glycoprotein from  CD4-independent strains of HIV to CXCR4 has not 
been examined but studies on the binding of envelope glycoproteins to the β-
chemokine receptor CCR5 in the presence of CD4 have demonstrated half-maximal 
inhibition of 125I-labelled MIP-1α (a CCR5 ligand) at concentrations from 
approximately 1 to 5nM (Hill et al. 1997; Wu et al. 1996).  Also, SIVmac239 gp120 
binds rhesus macaque CCR5 in the absence of CD4 with a KD of 14.36+3.90nM 
(Martin et al. 1997).  Therefore it  appears that there is indeed a high affinity 
interaction between FIV gp120 and CXCR4, implicating CXCR4 itself as the primary 
receptor for CrFK-adapted strains of FIV.  Our recent studies have demonstrated that 
transfection of murine or hamster cell lines with CXCR4 renders the cells permissive 
for fusion with FIV-infected CrFK cells (Willett et al. 1998) suggesting that either a 
highly conserved component of the feline, murine and hamster cell surface acts as the 
primary viral receptor or infection is mediated by CXCR4 alone, analogous to 
infection with CD4-independent strains of HIV-2.  In agreement with these findings, 
recent  studies by Poeschla and Looney (Poeschla and Looney, 1998) have 
demonstrated that replication-defective FIV pseudotypes based on the 34TF10 
molecular clone of FIV will infect human cells in the presence, but not in the absence, 
of human  CXCR4.  Furthermore, the post-entry  block to FIV infection that exists in 
human cells (Ikeda et al. 1996) would appear to be due to poor promoter activity of 
the FIV LTR U3 element (Poeschla and Looney, 1998) as when a heterologous 
promoter is substituted, efficient production of infectious FIV occurs. 
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Inhibition of FIV infection by CXCR4 antagonists 
 The natural ligand for CXCR4 has been identified as the chemokine SDF-1 
(stromal cell derived factor) (Bleul et al. 1996; Oberlin et al. 1996).  As we had 
demonstrated both a direct interaction between FIV Env and CXCR4 as well as 
competition between SDF-1 and FIV Env for binding to CXCR4, the antiviral activity 
of SDF-1 against FIV infection was evaluated.  Incubation of CrFK cells with either 
recombinant or synthetic SDF-1 resulted in a dose-dependent inhibition of infection 
with FIVPET (a subtype A isolate) (Hosie et al. 1998).  Subsequent experiments 
suggested that the inhibition of infection of CrFK cells was mediated by steric 
hindrance and not by down-modulation of CXCR4 expression as has been implicated 
as the antiviral principle for HIV-1 (Amara et al. 1997) since prolonged incubation of 
CrFK cells with SDF-1 led to enhanced expression of CXCR4 and increased 
susceptibility to FIV infection (Hosie et al. 1998).  Recent studies have suggested that 
SDF-1 has broad anti-viral activity against FIV and that the inhibition of infection 
extends not only to other antigenically distinct subtype A isolates, but also to isolates 
from subtype B and D (Endo et al. 1998).  Importantly, SDF-1 did not inhibit 
infection of the T-lymphoblastoid cell line Mya-1 with FIVPET (Hosie et al. 1998), 
suggesting the existence of a CXCR4-independent pathway of infection with FIV. 
However, Endo et al have observed inhibition of FIV infection by SDF-1β in the 
lymphoid cell line Kumi-1 (Endo et al. 1998) and Egberink et al demonstrated that 
infection of thymocytes with FIVUT113 is inhibited by the CXCR4 antagonist 
AMD3100 (Egberink et al. 1998). The studies by Endo et al and Egberink et al. are 
significant in that they suggest a role for  CXCR4 in infection with primary strains of 
FIV.  It is conceivable that the restricted tropism of primary isolates may the reflect a 
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requirement for expression of a high affinity primary receptor in conjunction with 
CXCR4 for infection to occur, analogous to the use of CD4 as a primary receptor by 
HIV, and that cell culture adaptation allows the virus to infect using CXCR4 alone. A 
precedent for this model has already been set with the discovery that CD4-
independent strains of HIV-2 use CXCR4 as the sole receptor for infection (Endres et 
al., 1996).  Future studies should therefore address the mechanism of FIV infection of 
Mya-1 cells in the presence of CXCR4 antagonists  to clarify whether infection of 
these cells is indeed CXCR4-independent.  
 The development of CXCR4 antagonists provides a potential source of 
therapeutic agents for the treatment of FIV-infected cats and HIV-infected human 
beings. We have compared a number of CXCR4-antagonists for the ability to inhibit 
FIV infection of CrFK cells and many of these agents have potent anti-viral activity. 
Figure 3 illustrates a comparison of the ability of three CXCR4 antagonists, namely 
AMD3100 (Donzella et al. 1998), ALX404C (Doranz et al. 1997) and Met-SDF, to 
inhibit infection of CrFK cells with FIVPET.  Each of the antagonists  inhibited FIV 
infection with a similar efficiency; 100% inhibition being observed at concentrations 
of between 10 and 100nM.  The concentrations of AMD3100 and ALX404C that 
inhibited FIV infection were similar to those inhibiting HIV-1 infection (Donzella et 
al. 1998; Doranz et al. 1997), again suggesting that FIV and HIV interact in a similar 
way with CXCR4 to promote infection. 
 
Mapping of domains on CXCR4 involved in FIV infection 
The discovery that FIV interacts specifically with the chemokine receptor 
CXCR4 suggests that despite the evolutionary divergence of  FIV and HIV, the 
envelope glycoproteins of FIV and HIV share conserved structural features enabling a 
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high affinity interaction.   Several studies have  demonstrated that  the alterations in 
the V3 loop that generate an SI phenotype select for usage of CXCR4 as a coreceptor 
(Choe et al. 1996; Speck et al. 1997), suggesting that the V3 loop contributes to the 
CXCR4 binding site.  Given that mutations in the V3 loop of FIV select for CrFK 
adaptation and usage of CXCR4 as a receptor, the data suggest that the CXCR4 
binding sites of both viruses are structurally similar  and that the V3 loop contributes 
to the structure.   The interaction between HIV and CXCR4 has been investigated 
using a series of chimaeric CXCR4 molecules generated between CXCR4 and the 
related α-chemokine receptor CXCR2.  These studies demonstrated that the first and 
second extracellular loops of CXCR4 were found to be important determinants of the 
interaction with CD4-dependent T-tropic or dual-tropic strains of HIV(Lu et al. 
1997). In contrast, M-tropic strains could only use CXCR4 when the amino terminus 
was substituted with that of CCR5(Lu et al. 1997).  Similarly, when chimaeras were 
generated between human CXCR4 and the rat homologue of CXCR4, the second 
extracellular loop  was found to be the principal determinant of CXCR4-usage by the 
NDK strain of HIV-1 (Brelot et al. 1997). In agreement with these findings, 
chimaeras constructed between murine and human CXCR4 have demonstrated that 
the second loop of human CXCR4 expressed in the context of murine CXCR4 renders 
canine thymocytes susceptible to infection with HIV-1 strains that are unable to use 
murine CXCR4 as a receptor (Parolin et al. 1998). 
In recent studies, we have investigated the interaction between FIV and 
CXCR4 using the panels of chimaeric CXCR4 molecules described above. Using rat 
CXCR4/human CXCR4 chimaeras (Brelot et al. 1997) the principal determinant of 
CXCR4 usage by FIV was localised to the second extracellular loop; a chimaeric 
molecule derived almost entirely from rat CXCR4, except for the second extracellular 
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loop which was derived from human CXCR4, supported both fusion and infection 
with similar efficiency to the parent human CXCR4 molecule (Willett et al. 1998).  
When similar studies were performed using  human CXCR2/human CXCR4 
chimaeras, substitution of the first or third extracellular domains of CXCR4 with the 
corresponding domains of CXCR2 rendered the molecule non-functional as an FIV 
receptor.  The data suggest that either the first and third extracellular loops of CXCR4 
contribute to the FIV Env binding site or that these domains are required to present 
the second extracellular loop in the appropriate conformation for the interaction with 
the FIV Env. Previous studies have suggested that the N-terminal extracellular 
domain of CXCR4 is required for CXCR4 to function as a coreceptor for some strains 
of HIV (Lu et al. 1997). However, mutant CXCR4 molecules in which the N-terminus 
was either replaced with the corresponding domain of CXCR2, or was removed 
completely to form a truncated molecule, supported both fusion and infection with 
CrFK-adapted FIV (Willett et al. 1998), suggesting that this portion of the molecule is 
not required for the interaction with FIV Env.   
 
Conclusions 
 Adaptation of FIV to replicate in the CrFK cell line is accompanied by the 
selection of viruses that are capable of interacting with the chemokine receptor 
CXCR4. These CXCR4-dependent strains of FIV may be analogous to CD4-
independent strains of HIV-2 that appear to interact directly with CXCR4 (Endres et 
al. 1996).  Indeed, it has been demonstrated recently that the second extracellular loop 
of CXCR4 is the principal determinant of CXCR4 usage by HIV-2 ROD/B (Reeves et 
al. 1998).  There are a number of striking similarities between CrFK-adapted strains 
of FIV and HIV-2 ROD/B.  Adaptation of FIV to a CrFK-tropic phenotype is 
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accompanied by a glutamate to lysine switch in the V3 loop of the virus, increasing 
the net charge of the V3 loop.  Also, a similar mutation in the V3 loop of HIV-2 
ROD-B (mutation of glutamine 310 to lysine) enhances the CD4-independent 
phenotype(Reeves and Schultz, 1997) of the virus.  Furthermore, while a methionine 
751 to threonine mutation in the TM protein of FIV is associated with the CrFK-
tropic phenotype(Vahlenkamp et al. 1997), a similar alanine 526 to threonine 
mutation in the TM protein of HIV-2 ROD is observed upon adaptation to a CD4-
independent phenotype(Reeves and Schultz, 1997), in each case the mutations are 
located adjacent to the region of TM thought to be involved in the formation of a 
coiled-coil  domain involved in oligomerization, viral entry and neutralization (Cao et 
al. 1993; Dubay et al. 1992; Ho et al. 1987; Muster et al. 1993; Wild et al. 1993).  
Although  mutations in other regions of the env gene are thought to be necessary to 
confer a CrFK-tropic phenotype on FIV (Siebelink et al. 1995; Vahlenkamp et al. 
1997; Verschoor et al. 1995), and a CD4-independent phenotype on HIV-2 (Reeves 
and Schultz, 1997),  both viruses adapt in a similar way to the use of pathways for 
infection that  result ultimately in the use of CXCR4 alone as a viral receptor.  These 
studies suggest that common structural motifs remain despite the divergence in amino 
acid sequence between FIV and HIV.  By comparing the mechanism of infection with 
the feline and human lentiviruses, it may be possible to define the regions of the Env 
protein that are essential for the chemokine receptor interaction and ultimately to 
design novel therapeutic agents that can be used in the treatment of lentiviral diseases.  
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Figure Legends 
 
Figure 1. Amino acid sequence mutations in the V3 loop of FIV that select for growth 
in the CrFK cell line. Adaptation involves the mutation of either of two glutamate 
residues, residues 407 and 409 (numbering according to the FIVPET-F14 sequence, 
Genbank accession number M25381) to lysine, increasing the net charge of the V3 
loop. E to K mutations are present in the 34TF10 (Talbott et al. 1989), F14 (Olmsted 
et al. 1989), UT113Cr (Verschoor et al. 1995) and 19K1PBAM6 (Siebelink et al. 
1995) strains of FIV, all of which have been selected for growth in CrFK cells. 
 
Figure 2.  Inhibition of syncytium formation between FIV-infected CrFK cells and 
Hela cells by anti-CXCR4 antibody. Hela cells were incubated for 1 hour with 
25μg/ml of either the anti-CXCR4 antibody 12G5, the anti-CD9 antibody vpg15 or 
the anti-FIV envelope antibodies vpg67 and 71.2; a 1:20 dilution of a serum from an 
FIV infected cat (Q71) or a 1:20 dilution of a polyclonal goat serum raised against the 
feline endogenous retrovirus RD114. FIVPET-infected CrFK cells were then added and 
incubated for 18 to 24 hours at which time the cells were fixed, stained and the 
number of syncytia per field enumerated. 
 
Figure 3. Inhibition of FIV infection by CXCR4 antagonists.  CrFK cells were 
incubated with a dilution series of the CXCR4 antagonists AMD3100, ALX404C and 
met-SDF for 1 hour.  Virus was added to the cells and incubated for 1 hour at 37oC.  
The cells were then washed twice with culture medium and then re-fed with medium 
containing antagonist. Supernatants were collected 5 days post-infection and assayed 
for viral core protein p24 by ELISA.  
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